Gene · 2931
Papers2,889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,889
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder. | Front Neurosci | 2023 | 37592949 | PubTator, text mining | PubMed |
| Multi-Target Neural Differentiation (MTND) Therapeutic Cocktail to Suppress Brain Tumor. | Int J Mol Sci | 2023 | 37569705 | PubTator, text mining | PubMed |
| Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features. | Int J Mol Sci | 2023 | 37569304 | PubTator, text mining | PubMed |
| CMGC Kinases in Health and Cancer. | Cancers (Basel) | 2023 | 37568654 | PubTator, text mining | PubMed |
| Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling. | Clinics (Sao Paulo) | 2023 | 37557005 | PubTator, text mining | PubMed |
| Identification of microbial metabolites that accelerate the ubiquitin-dependent degradation of c-Myc. | Oncol Res | 2023 | 37547761 | PubTator, text mining | PubMed |
| Sucralose Targets the Insulin Signaling Pathway in the SH-SY5Y Neuroblastoma Cell Line. | Metabolites | 2023 | 37512524 | PubTator, text mining | PubMed |
| MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer. | Cells | 2023 | 37508580 | PubTator, text mining | PubMed |
| Identification of antimycin A as a c-Myc degradation accelerator via high-throughput screening. | J Biol Chem | 2023 | 37495110 | PubTator, text mining | PubMed |
| Compilation of reported protein changes in the brain in Alzheimer's disease. | Nat Commun | 2023 | 37491476 | PubTator, text mining | PubMed |
| Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology. | Elife | 2023 | 37490324 | PubTator, text mining | PubMed |
| Upregulation of endocytic protein expression in the Alzheimer's disease male human brain. | Aging Brain | 2023 | 37449017 | PubTator, text mining | PubMed |
| The Therapeutic Value of Solanum Steroidal (Glyco)Alkaloids: A 10-Year Comprehensive Review. | Molecules | 2023 | 37446619 | PubTator, text mining | PubMed |
| Exploring the Role of Circulating Cell-Free RNA in the Development of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446204 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction. | Int J Mol Sci | 2023 | 37446034 | PubTator, text mining | PubMed |
| MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming. | Adv Sci (Weinh) | 2023 | 37442756 | PubTator, text mining | PubMed |
| High-throughput Oligopaint screen identifies druggable 3D genome regulators. | Nature | 2023 | 37438531 | PubTator, text mining | PubMed |
| Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics. | Nutrients | 2023 | 37432240 | PubTator, text mining | PubMed |
| Novel Coumarin-furo[2,3-d]pyrimidinone hybrid derivatives as anticancer agents: Synthesis, biological evaluation and molecular docking. | Eur J Pharm Sci | 2023 | 37423580 | PubTator, text mining | PubMed |
| Large-scale pathogenicity prediction analysis of cancer-associated kinase mutations reveals variability in sensitivity and specificity of computational methods. | Cancer Med | 2023 | 37409618 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2931/papers?page=9